|
|
 |
|
Viewing report
|
|
|
|
Epidemiology: Depression
Datamonitor, Dec 2010, Pages: 32
Depression is a very prevalent disease in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK) that affects millions of people and results in severe disability in many people who are affected by it. It will continue to affect large numbers of people over the next ten years.
Scope of the report:
- Gain insight to market potential, including a robust 10-year epidemiology forecast of prevalent depression cases.
- Understand the key epidemiologic risk factors associated with depression.
Highlights:
The prevalence of major depressive disorder (MDD) has been steady in the past several decades in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). The major risk factors are unlikely to change between 2010 and 2020, so the prevalence rate will remain roughly consistent during the forecast period.MDD is a predominant psychiatric disorder in the seven major markets.
In 2010, it is estimated that there will be around 39.0 million cases of major depression in those aged over 18 in the seven major markets during the year; this is expected to increase to approximately 40.7 million cases during the year 2020.
It is etimated that the number of cases of MDD in those over age 18 in the seven major markets will increase by around 0.20% on average. The highest average annual increase is forecast to be in the US (1.00% per year) and the largest average annual decrease will be in Japan (-0.06% per year).
Key questions answered:
- What are the most robust epidemiology studies for depression prevalence data?
- How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure and risk factors affect the number of prevalent depression cases in the forecast period?
|
|
|
|
